Search

everythinglearnresearchcommunity

for

Search:↓

The cream effectively treats scalp psoriasis, improving symptoms and quality of life, with high patient satisfaction.

Topical 1% pimecrolimus effectively treated alopecia areata.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Clascoterone cream 1% is effective and well-tolerated for treating acne and other related conditions.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Mesalazine showed limited effectiveness in treating children with severe alopecia areata.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Dupilumab may help regrow hair in people with atopic dermatitis.

Dutasteride is more cost-effective than finasteride for treating benign prostatic hyperplasia in Montenegro.

High-dose UVA-1 therapy improves symptoms and skin condition in sclerosing skin disease.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Clofazimine effectively treated ashy dermatosis in a patient.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Clascoterone is a promising topical treatment for hair loss and acne with fewer side effects.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

These new skin treatments are safer and more effective with minimal side effects.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Tofacitinib may effectively treat folliculitis decalvans.